For lower-stakes COVID-19 checks, rapid antigen tests offer a quick and simple way to screen for SARS-CoV-2 at home. They can be particularly helpful if you know or suspect youve been exposed to the coronavirus but cant access professional testing (or wait for the results).
FDA-authorized at-home antigen diagnostic tests can detect active COVID-19 infections, including in asymptomatic individuals, in about 15 minutes. Overall, these tests are less sensitive than molecular diagnostic tests done in labs. Still, the results of at-home antigen testing can provide additional dataif not total peace of mindregarding ones COVID-19 status, especially if you test frequently. Depending on your situation, it may make sense to have a few of these tests on hand.
Keep in mind that a negative result doesnt necessarily mean someone doesnt have COVID-19, and these tests arent meant to be used as the sole method of diagnosis. Antigen tests are a cheap and easy way to identify a person who may be contagious, said Dr. Matthew McCarthy, an associate professor of medicine at Weill Cornell Medical College. For people with no known COVID-19 exposures, if youre going to Thanksgiving, and theres 20 people there and theyre all fully vaccinated, you can do an antigen test before you go to make sure youre not bringing the virus into the party, he said, citing one potential use.
Taking a rapid antigen test might also be appropriate before interacting with someone who may be more vulnerable to contracting the virus. Even people who are fully vaccinated may want to take one of these convenient at-home tests before going to spend time with Grandma, or whatever it may be, said Dr. Clare Rock, a clinical epidemiologist at Johns Hopkins University School of Medicine who runs a COVID-19 infection-control consultancy.
At-home COVID-19 antigen tests are accessible and fast. Rather than waiting for an appointment (or ordering a mail-in kit and shipping a sample) and then waiting for the results of a molecular diagnostic test, with an at-home antigen test you can generally go from swab to result in as few as 15 minutes. The tests are generally easy to perform, and you can read the results manually (as with a home pregnancy test) or digitally (with an app).
COVID-19 antigen tests are less sensitive than molecular diagnostics. Unlike molecular diagnostic tests for COVID-19 that involve amplifying viral nucleic acids to the point where they can be more easily detected, antigen tests detect unamplified traces of virus and thus dont pick up small signals as readily. (Antigen tests are not to be confused with antibody tests, which are meant to detect antibodies produced to respond to the virus, and are not used for diagnostic purposes.)
Although at-home antigen tests are not fail-safe, even molecular diagnostics like the gold-standard PCR tests are not always accurate when it comes to detecting active COVID-19 cases, since results depend on, among other things, the timing of the test. If youre swabbed too soon after an exposure, you may test negative even if you are carrying the virus. You can also receive a positive PCR test result after youre no longer infectious.
Compared with molecular diagnostics for COVID-19, antigen tests are not as sensitive if were looking to understand is there any even minute piece of virus present, clinical epidemiologist Rock said, but they are very sensitive if were looking to see is there a level of the virus that we have to be concerned that somebody could transmit to someone else.
There are nine SARS-CoV-2 antigen tests from five companies now authorized by the FDA for emergency use at home. These are variations of Abbotts BinaxNow COVID-19 Antigen Self Test, Access Bios CareStart COVID-19 Antigen Home Test, Ellumes COVID-19 Home Test, the InteliSwab COVID-19 Rapid Test from OraSure Technologies, and the Quidel QuickVue At-Home COVID-19 Test. Of these, the Abbott BinaxNow, Ellume COVID-19 Home, and Quidel QuickVue tests are currently available direct to consumers, without a prescription, in pharmacies and online.
The instructions that accompany all of these tests include a disclaimer that negative results may require additional testing for confirmation. For each of them, theres a small chance of false positive results, too.
We typically recommend getting tested three to five days after exposure.Dr. Matthew McCarthy, Weill Cornell Medical College
The accuracy of an at-home antigen test depends in part on test sensitivity (the tests reported ability to detect a true positive), test specificity (its reported ability to detect a true negative), sample integrity (whether a swab contains enough sample or the swab solution is contaminated by, say, another pathogen), whether one follows the manufacturers instructions exactly, the time since a persons last known or suspected exposure and/or their onset of symptoms, and ones viral load at the time of testing. (The tests are currently authorized for use on people as young as 2, provided any childs sample is obtained and processed by an adult.)
For a test to be considered for emergency use authorization, test makers must submit to the FDA clinical data demonstrating test sensitivity and specificity. Some independent studies have shown much lower sensitivity and specificity for some antigen tests, particularly when theyre used on asymptomatic individuals. (There is one commercially available SARS-CoV-2 molecular diagnostic test currently authorized by the FDA for emergency use entirely at home, meaning you dont need to send a sample off to a lab for testing: the Lucira COVID-19 All-In-One Test Kit. It is slightly more sensitive95.2%compared with some FDA-authorized at-home antigen tests, and it provides results in 30 minutes. But it is currently unavailable on Luciras website and at Amazon, where it was once sold.)
At the time of publication, at-home antigen tests were hard to find because a surge in COVID-19 cases caused a spike in demand for them. If you have trouble finding them online, call local pharmacies (these tests are often stocked behind the front counter).
Abbott BinaxNow COVID-19 Antigen Self TestSensitivity: 84.6% (PDF) (within seven days of symptom onset)Specificity: 98.5% (PDF) (within seven days of symptom onset)Tests included: twoCost: $24Availability: Amazon, CVS, Walmart
Ellume COVID-19 Home Test (app required)Sensitivity: 95% (PDF)Specificity: 97% (PDF)Tests included: oneCost: $35Availability: Amazon, CVS, Target
Quidel QuickVue At-Home COVID-19 TestSensitivity: 84.8% (PDF)Specificity: 99.1% (PDF)Tests included: twoCost: $25Availability: Amazon, Walmart
The key to getting trustworthy antigen test results is testing frequently. Serial testing boosts sensitivity, said Christoper Brooke, an infectious diseases expert at the University of Illinois at Urbana-Champaign. The odds that youre going to test negative twice when youre infected are much lower than the odds that youre going to test negative once.
Rather than having a swab shoved up into the nasopharyngeal cavity, which you might encounter at a clinical testing site, the at-home antigen tests from Abbott, Ellume, and Quidel require a less-penetrative mid-nasal swab. Each test comes with specific instructions, which essentially require that you swab your nose, dip the swab into a solution, transfer some of the solution into a small reservoir, and wait for the result.
After 15 minutes or so, you can read the results of the Abbott BinaxNow and Quidel QuickVue tests much like you would a home pregnancy test: Two lines indicate a positive result, and one line (the control) indicates a negative. A very faint second line can still indicate a positive result. The Ellume COVID-19 Home Test requires Bluetooth connection to a phone to provide results in 15 minutes via a companion app (iOS, Android). According to the companys privacy policy, Ellume must provide public health authorities with the users date of birth and their state and zip code of residence, test result, test result date, and possibly other information as required by law.
As is true for all COVID-19 diagnostics, including PCR tests, the timing of sample collection against the last known or suspected exposure and/or symptom onset is the biggest factor that can affect the accuracy of at-home antigen test results. This is why, for example, Abbotts BinaxNOW and Quidels QuickVue test kits come with two tests, intended to be used between two and three days apart.
The sensitivity of a test really depends on when you use it, said Daniel Larremore, an assistant professor of computer science at the University of Colorado Boulder who has modeled the effects of repeated population screening of asymptomatic people with molecular and antigen tests. An infected persons viral load changes over time. When you reach a high enough viral load, antigens are going to be at a high enough concentration to be detected. Testing yourself the day after attending a party with someone who didnt know they had COVID-19 at the time is unlikely to be useful. Twenty-four hours after exposure, no test is going to be positive, Larremore said. If you wait too long to test, you may miss peak antigen concentration, meaning you should see a fainter positive line if the test detects SARS-CoV-2 antigens in your sample.
We typically recommend getting tested three to five days after exposure, said McCarthy of Weill Cornell. If you have COVID-19like symptoms, theres no need to wait to test.
Consult a physician if youre unsure of or confused by the result of an at-home COVID-19 antigen test. Whether you should seek a confirmatory molecular test depends on your circumstances. One should treat a positive antigen test result as a true positive, said Larremore, particularly if additional factorssuch as a potential exposure or the appearance of symptomssupport the result. This means isolating, alerting any contacts, and possibly seeking to confirm the result with a lab test. Seek medical treatment for symptoms as needed. According to Weill Cornells McCarthy, following up on a negative antigen test result with a confirmatory molecular diagnostic may not be necessary in cases where someone has a low suspicion of having COVID-19 (for example, they are asymptomatic, fully vaccinated, and/or have no known exposures).
Getting a lab-performed PCR test is your best bet for an accurate COVID-19 diagnosis, but appointments can be difficult to get, and sometimes it takes so long to get the results that they are useless, said Brooke of the University of Illinois. Ideally everyone would have frequent PCR testing with rapid results reporting, but thats obviously not possible. Antigen tests are often the only really viable available choice, so they can play a really important role in increasing the frequency of testing, and the breadth of testing, across the population.
Visit link:
At-Home COVID-19 Antigen Tests: What You Should Know - The New York Times
- Exercise promotes a molecular profile in muscle: Research - January 21st, 2023
- Molecular Diagnostics Laboratory < Laboratory Medicine - January 4th, 2023
- Molecular cloning - Wikipedia - December 18th, 2022
- Trends in Molecular Medicine | Journal - ScienceDirect - December 10th, 2022
- Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravel molecular secrets hidden in premature aging diseases... - December 2nd, 2022
- Nuclear Medicine and Molecular Imaging Week: October 2-8, 2022 - October 29th, 2022
- Biochemistry & Molecular Biology | Medicine - October 29th, 2022
- Cellular and Molecular Medicine | Faculty of Medicine - October 21st, 2022
- Molecular Diagnostics > Fact Sheets > Yale Medicine - October 21st, 2022
- Expert Reviews in Molecular Medicine | Cambridge Core - October 13th, 2022
- UT Southwestern ranked top health care institution globally for published research by Nature Index - UT Southwestern - October 13th, 2022
- Common Antibiotics Are Losing Their Potency. Researchers Pinpoint Mechanism to Restore It. - NYU Langone Health - October 13th, 2022
- expert reaction to study looking at integrating human stem cell-derived brain-like tissue in the brains of newborn rats - Science Media Centre - October 13th, 2022
- HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery - Yahoo Finance - October 13th, 2022
- UVA Discovers Key Driver of High Blood Pressure - UVA Health Newsroom - October 13th, 2022
- Postdoctoral Fellow in Lung Cancer Genomics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311727 - Times Higher Education - October 13th, 2022
- Common cold may increase the risk of long Covid - Earth.com - October 13th, 2022
- Caris' Precision Oncology Alliance Welcomes The Cancer Institute at The University of Tennessee Medical Center - PR Newswire - October 13th, 2022
- Merus Announces Publication of Abstract on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics - Yahoo... - October 13th, 2022
- Molecular Test Could Improve Early Detection of Pancreatic Cancer - Technology Networks - October 13th, 2022
- UTSW researchers identify key player in cellular response to stress - EurekAlert - October 4th, 2022
- New Antibody Demonstrates Therapeutic Benefits Against Alzheimers - SciTechDaily - October 4th, 2022
- Mount Sinai study uncovers mechanisms of reactive oxygen species in stem cell function and inflammation prevention - EurekAlert - October 4th, 2022
- NovoPath Pushes the Limits of Laboratory Information Systems with Integrated Workflows for Genetic and Molecular Testing - PR Newswire - October 4th, 2022
- Postdoctoral Fellow in Bioinformatics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311073 - Times Higher Education - October 4th, 2022
- Breast Cancer Awareness | Nick Jacobs | An unlikely partnership: The United States Army Space and Missile Defense Command and the Joyce Murtha Breast... - October 4th, 2022
- Tackling resistance to HIF2 drugs with an RNA-based therapy - UT Southwestern - October 4th, 2022
- OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an adjunct to Cytoreductive Surgery of Peritoneal Carcinomatosis - Business... - October 4th, 2022
- SIMATS organizes Induction Ceremony - Afternoonnews - Afternoon News - October 4th, 2022
- ExPath Grad Student Madeline Mayday Awarded Grant from the NIDDK Cooperative Centers of Excellence in Hematology - Yale School of Medicine - September 25th, 2022
- Blood Cancer Discovery Publication Further Validates Exscientia's AI Precision Medicine Platform for Improving Patient Outcomes - Business Wire - September 25th, 2022
- New Startups Built From UC Davis Innovations Drive Solutions in Food, Health and Agriculture - University of California, Davis - September 25th, 2022
- Scientists Discover New Cancer Treatment - The Morning News - September 25th, 2022
- Rewriting the Textbook for Precision Medicine - Technology Networks - September 25th, 2022
- Biden says 'The pandemic is over,' but health experts disagree - Chief Healthcare Executive - September 25th, 2022
- Discovery Illuminates How Parkinson's Disease Spreads in The Brain - Weill Cornell Medicine Newsroom - September 25th, 2022
- AI Used to Determine Cause of Alzheimer's and Related Disorders - Inside Precision Medicine - September 25th, 2022
- Looking Ahead in the Treatment of Breast Cancer - Targeted Oncology - September 25th, 2022
- Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children - EurekAlert - September 25th, 2022
- New study reveals breakthrough infections increase immunity to COVID-19 - OHSU News - September 25th, 2022
- Coronavirus Today: Who's dying of COVID-19 now? - Los Angeles Times - September 25th, 2022
- Hoag Named Radiopharmaceutical Therapy Center of Excellence, Publishes Results of Breast and Prostate Cancer Trials - PR Newswire - September 8th, 2022
- Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines - Yahoo Finance - September 8th, 2022
- Scientists urged the Biden administration to launch an Operation Warp Speed to develop inhaled COVID vaccines. China beat the U.S. to the punch -... - September 8th, 2022
- Foundation Medicine to Share 14 Abstracts at the 2022 European Society for Medical Oncology (ESMO) Congress Demonstrating the Power of Genomic... - September 8th, 2022
- Monte Rosa Therapeutics Announces FDA Clearance of Investigational New Drug Application for MRT-2359, a GSPT1-directed Molecular Glue Degrader Phase... - September 8th, 2022
- Biden administration says the once-a-year shot phase of the COVID-19 pandemic has arrived - The Boston Globe - September 8th, 2022
- ICCBS welcomes students of MPhil and PhD Programs 2022 - The Academia Mag - September 8th, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 308114 - Times... - September 8th, 2022
- Congratulations to our NRF award winners | UCT News - University of Cape Town News - September 8th, 2022
- Patients with some forms of aggressive esophageal cancers may benefit from treatment targeting how cells self-regulate - EurekAlert - September 8th, 2022
- Molecular Medicine (M.Sc.) - Georg-August-Universitt Gttingen - August 30th, 2022
- Gradalis Announces Publication in Nature Communications Medicine Identifying Survival Predicting Biomarker in Patients with Ovarian Cancer Treated... - August 30th, 2022
- Feinstein Institutes Get $3M From Lupus Research Alliance to Study Remission and Future Therapies - Business Wire - August 30th, 2022
- Unlocking the Power of Precision Medicine the Rheumatology Example - Technology Networks - August 30th, 2022
- When to trust your covid test results and when to question them | Mint - Mint - August 30th, 2022
- Molecular Diagnostics Market Report 2022-2030: Increasing Adoption of Point-Of-Care (Poc) Testing and the Development of Novel Assays Presents... - August 30th, 2022
- Advancing Precision Oncology, Ochsner Health First to Fully Integrate with Tempus and Epic's Genomics Module - Newswise - August 30th, 2022
- Tiny, Touch-Based Sensor Could Help Patients Stay on Top of Their Medications - SciTechDaily - August 30th, 2022
- Stellar Scholars Join CLAS Faculty - UConn Today - University of Connecticut - August 30th, 2022
- COVID-19 gave new urgency to the science of restoring smell - Science News Magazine - August 30th, 2022
- Dr. Sun lab wins R01 from National Institutes of Health to study liver proteins - Wayne State University - August 22nd, 2022
- Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference - GlobeNewswire - August 22nd, 2022
- New Study Identifies How A Group Of Genes Are Linked To Behavioral Conditions - Forbes - August 22nd, 2022
- New gene variant that protects against coronary heart disease uncovered - EurekAlert - August 22nd, 2022
- How a Japanese Herbal Medicine Protects the Gut Against Inflammatory Bowel Disease - Neuroscience News - August 22nd, 2022
- Insilico Medicine presents on AI for drug discovery at 9th Annual Aging Research and Drug Discovery Conference - EurekAlert - August 22nd, 2022
- Why polio is back on the radar of Canadian health officials - Brighter World - August 22nd, 2022
- Angela DeMichele, MD, MSCE, Assesses the Value of I-SPY2 for Neoadjuvant Treatment of Early Breast Cancer - Cancer Network - August 22nd, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 304753 - Times... - August 22nd, 2022
- Sensor could help patients stay on top of their meds - EurekAlert - August 22nd, 2022
- Trivitron Healthcare launches CoE in metabolomics, genomics, newborn screening and molecular diagnostics - Express Healthcare - August 22nd, 2022
- Research Trends of Moxibustion Therapy for Pain Treatment Over the Pas | JPR - Dove Medical Press - August 22nd, 2022
- Edited Transcript of EXAI.OQ earnings conference call or presentation 18-Aug-22 12:30pm GMT - Yahoo Finance - August 22nd, 2022
- Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75 - PR Newswire - August 22nd, 2022
- Will Omicron BA.5 Be the Last of the COVID Variants? - The Epoch Times - August 22nd, 2022
- Many Paths to Failure | Harvard Medical School - Harvard Medical School - August 5th, 2022
- Mitochondrial DNA Mutations Linked to Heart Disease Risk - University of California San Diego - August 5th, 2022
- UC Davis Sets a New Record, Surpasses $1 Billion in Research Funding - University of California, Davis - August 5th, 2022
- A first update on mapping the human genetic architecture of COVID-19 - Nature.com - August 5th, 2022